Our Vision
Change the future of vision care.
Our Mission
Eliminate needless vision loss and blindness with high quality, affordable, and easy-to-use digital vision screening that is accessible for everyone, globally.
Our Passion
Retina Technologies was founded by five medical students in 2018 who wanted to find a way to make quality vision screening accessible to underserved populations using advanced digital technologies. When working as volunteers in clinics located in these communities, they saw too many patients with undiagnosed, advanced vision loss. What was most alarming was the discovery that with early diagnosis and treatment, 80% of these patients would still have their vision.
Over 24% of counties in the United States alone don't have an optometrist or ophthalmologist. Adding to this shortage of vision care specialists is the $150,000 or more it can cost to equip a vision care office, plus the necessary training required to properly use this equipment.
Their mission, ultimately focused the team on primary care physicians (PCP) as an ideal path, or workflow, to bring comprehensive digital vision screening to virtually any community, anywhere. The solution had to be simple, quick, and provide consistent, trusted results.
With this goal in mind, OcuVue™ was designed from the ground up to be an affordable, comprehensive, end-to-end vision screening solution that brings PCPs, vision care providers, and vision specialists closer together for the prevention of blindness.
Integrating OcuVue™ as part of a PCPs daily routine, patients will ultimately be able to get fast, regular, visual function exams and retinal imaging, all in about 15 minutes without getting out of their chair! Our proprietary ML algorithms then process this data in seconds, and provide a simple referral recommendation to specialists when visual abnormalities are detected.
For PCPs and health care providers, this means a new revenue stream for under-resourced PCPs, and with more patients referred to vision specialists through early detection, better outcomes for everyone. We believe OcuVue™ will play a vital role in helping people keep their sight.
*The OcuVue™ prototype and associated technologies are not commercially available.
Led by Harvard Business Alumni Angels of Greater New York, accompanied by our strategic partners, RetTech raises a total of $268K to further development efforts.